Market Overview

Goldman Sachs Maintains Neutral on Merck & Company, Inc., Lowers PT to $47.00

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for MRK

DateFirmActionFromTo
Nov 2014JefferiesMaintainsHold
Oct 2014JefferiesMaintainsHold
Oct 2014Guggenheim SecuritiesInitiates Coverage onNeutral

View More Analyst Ratings for MRK
View the Latest Analyst Ratings

Posted-In: News Price Target Analyst Ratings

 

Related Articles (MRK)

Around the Web, We're Loving...

Get Benzinga's Newsletters